Перейти к содержанию

Embecta Corp. (EMBC) stock: revenue, earnings & dividend

Embecta Corp. (EMBC, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener EMBC · Nasdaq Medizintechnik & Messgeräte US-NJ

Key figures

Fiscal year
2025
Revenue
1.08 bn $
Revenue growth
-3.8 %
Revenue growth 5y (p.a.)
-0.1 %
Net income
95.4 m $
Net margin
8.8 %
Operating margin
22.4 %
Earnings per share (diluted)
1.62 $
Dividend per share
0.60 $
Payout ratio
37 %
Consecutive dividend years
4 years
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
1.06 bn $
Equity
-613.1 m $
Equity ratio
-57.6 %
Return on equity
–
Cash
201 m $
Operating cash flow
192 m $
Free cash flow
182 m $
Shares outstanding
56,659,599

History

Revenue by fiscal year

2020 1.09 bn $
2021 1.17 bn $
2022 1.13 bn $
2023 1.12 bn $
2024 1.12 bn $
2025 1.08 bn $

Net income by fiscal year

2020 428 m $
2021 415 m $
2022 224 m $
2023 70.4 m $
2024 78.3 m $
2025 95.4 m $

Dividend per share

2022 0.15 $
2023 0.60 $
2024 0.60 $
2025 0.60 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.08 bn $95.4 m $1.62 $0.60 $192 m $
20241.12 bn $78.3 m $1.34 $0.60 $35.7 m $
20231.12 bn $70.4 m $1.22 $0.60 $67.7 m $
20221.13 bn $224 m $3.89 $0.15 $412 m $
20211.17 bn $415 m $7.28 $–456 m $
20201.09 bn $428 m $7.50 $–499 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)